Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer (Q52018331)

19 April 2018

title

Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer (English)

1 reference

19 April 2018

adaptive radiation therapy

main subject

0 references

Ranald I Mackay

3

0 references

author name string

Ali M Amer

1

1 reference

19 April 2018

Judith Mott

2

1 reference

19 April 2018

Peter C Williams

4

1 reference

19 April 2018

Jacqueline Livsey

5

1 reference

19 April 2018

John P Logue

6

1 reference

19 April 2018

Jolyon H Hendry

7

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 May 2003

1 reference

19 April 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

19 April 2018

volume

56

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

199-207

1 reference

19 April 2018

Fractionation and protraction for radiotherapy of prostate carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Toward optimal external-beam fractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Cell production rates in human tissues and tumours and their significance. Part II: clinical data

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984).

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Hypofractionation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Retrospective study of radiotherapy in early carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Tumour and normal tissue responses to fractionated non-uniform dose delivery

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Short-course intensity-modulated radiotherapy (70 GY at 2.5 GY per fraction) for localized prostate cancer: preliminary results on late toxicity and quality of life

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

The required number of treatment imaging days for an effective off-line correction of systematic errors in conformal radiotherapy of prostate cancer--a radiobiological analysis

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(03)50086-5

7 January 2021

10.1016/S0360-3016(03)00086-5

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018